Subscribe to RSS
DOI: 10.1055/s-0042-1749447
Homeopathic Treatment in Patients with COVID-19: Analysis of Clinical Evolution and Comparison between Cases in 2020 and 2021
Abstract
Background The manifestations of coronavirus disease 2019 (COVID-19) can result in several prognoses and lead patients to look for appropriate complementary or alternative treatment options according to their personal situation and available health care. Patients with mild symptoms or those who have not yet reached the maximum severity of their condition are those who seek outpatient care, where homeopathic treatment might be considered, given the well documented history of this medical system in several epidemics in the past.
Objective The aim of this study was to compare the homeopathic treatment used for symptomatic cases of COVID-19 in March and April 2020 with cases treated in March and April 2021.
Method This is a retrospective observational study based on the analysis of the medical records of symptomatic COVID-19 patients treated on an outpatient basis with homeopathy at the Hahnemanniano George Galvão Institute in São Paulo, Brazil. We analyzed 54 cases, divided into two samples (27 cases in each year), similar in relation to age, gender and origin of the patients.
Results The development was distinct in the 2 years, with improvement of symptoms after 3 days of the first homeopathic prescription in 2020 whilst in 2021 the improvement occurred from the sixth day onward. The most frequently prescribed homeopathic medicine also differed in the two samples (Antimonium tartaricum in 2020; Arsenicum album in 2021), which indicates the different disease characteristics at these two moments of the epidemic.
Conclusion In 2020, the symptomatology of the cases was mainly acute and the main medicine was Antimonium tartaricum. By comparison, in 2021 a greater interference from individuals' previous chronic miasmatic disease may explain the change in the main medicines used that year, with Arsenicum album being the most prescribed in the cases studied.
Publication History
Received: 08 November 2021
Accepted: 01 February 2022
Article published online:
01 September 2022
© 2022. Faculty of Homeopathy. This article is published by Thieme.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Hahnemann S. Materia Pure Medica. New Delhi: B. Jain Publishers; 2002
- 2 Hahnemann S. Cure and prevention of scarlet fever. In: Dudgeon RE. ed. Minor Writings of Samuel Hahnemann. São Paulo: Organon; 2006: 351-365
- 3 Hahnemann S. On the treatment of miliary purpura. In: Dudgeon RE. ed. Minor Writings of Samuel Hahnemann. São Paulo: Organon; 2006: 661-662
- 4 Hahnemann S. Treatment of typhus or hospital fever that predominates at the moment. In: Dudgeon RE. Minor Writings of Samuel Hahnemann. São Paulo: Organon; 2006: 597-600
- 5 Hahnemann S. Cause and prevention of Asian cholera. In: Dudgeon RE. ed. Minor Writings of Samuel Hahnemann. São Paulo: Organon; 2006: 717-720
- 6 Teixeira MZ. Homeopathy in epidemic diseases: concepts, evidence and proposals. Rev Homeopatia 2010; 73: 36-56
- 7 Gallant JER. History of Homeopathy in Brazil. Paper presented at: 1st Brazilian Congress of Homeopathy. Hahnemannian Institute of Brazil, Rio de Janeiro 1928
- 8 Daruiche PSJ. Homeopathy in Epidemics: Case Study Based on Recent Experiences (Master's thesis). São Paulo: Federal University of São Paulo; Paulista School of Medicine; 2012
- 9 Centers for Disease Control and Prevention. Interim Infection Prevention and Control Recommendations for Patients with Known or Patients Under Investigation for 2019 Novel Coronavirus (2019-nCoV) in a Healthcare Setting. Accessed March 30, 2020 at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html
- 10 Pan L, Mu M, Yang P. et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol 2020; 115: 766-773
- 11 World Health Organization. Global surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. March 20, 2020. Accessed May 6, 2020 at: https://apps.who.int/iris/handle/10665/331506
- 12 Valeri A, Pomposelli R, Pipitone S, D'arpa C. Symptomatic COVID-19 positive and likely patients treated by homeopathic physicians—an Italian descriptive study. ResearchGate. 2020
- 13 Brazil, Ministry of Health:, Secretariat of Science, Technology, Innovation and Strategic Health Supplies (SCTIE);, Department of Management and Incorporation of Technologies and Innovations in Health (DGITIS);, General Coordination of Health Technology Management (CGGTS);, Coordination of Management of Clinical Protocols and Therapeutic Guidelines (CPCDT).. Guidelines for diagnosis and treatment of COVID-19. Brasilia; April 06, 2020. Accessed April 22, 2020 at: https://sbim.org.br/images/files/notas-tecnicas/ddt-covid-19-200407.pdf
- 14 Centers for Disease Control and Prevention. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel: Instructions for Use. Accessed May 23, 2020 at: https://www.fda.gov/media/134922/download
- 15 Hahnemann S. Exposition of Homeopathic Doctrine, or Organon of the Art of Healing. 7th ed.. São Paulo: São Paulo Homeopathic Study Group; 2019
- 16 Martinez JAB, Padua AY, Terra Filho J. Dispneia. Med Ribeirão Preto 2004; 37: 199-207